文献速递肿瘤 PET/CT骨显像与常规 SPECT

初诊多发性骨髓瘤患者基线[18F]FDG PET/CT视觉IMPeTUs标准与代谢肿瘤负荷的预后价值

Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [18F]FDG PET/CT in patients with newly diagnosed multiple myeloma.
PubMed 文献 · EJNMMI Res · 2024-05-28

本研究在40例适合移植的初诊多发性骨髓瘤患者中回顾性评估基线[18F]FDG PET/CT视觉IMPeTUs参数及总代谢肿瘤体积(TMTV)的预后意义。两名核医学医师间一致性为中等至高度(Cohen's kappa 0.53–0.87)。多因素分析显示,SUV4.0阈值下勾画的感兴趣体积(VOI)数量多是PFS的独立预后因素[HR 1.03(95%CI 1.004–1.05),P=0.019],局灶性病变数>10个(F组4)是OS的独立预后因素[HR 19.10(95%CI 1.90–191.95),P=0.01];SUV4.0阈值勾画的TMTV预后价值不显著。

要点

  • IMPeTUs视觉标准在两名医师间一致性为中等至高度(Cohen's kappa 0.53–0.87)。
  • SUV4.0阈值勾画VOI数量多是PFS独立预后因素[HR 1.03(95%CI 1.004–1.05),P=0.019]。
  • 局灶性病变数>10个(F组4)是OS独立预后因素[HR 19.10(95%CI 1.90–191.95),P=0.01]。

核心结论

  • 本研究证实IMPeTUs标准具有可重复性。
  • 局灶性病变数>10个(IMPeTUs F组4)反映高[18F]FDG摄取肿瘤负荷,是OS的独立预后因素。
  • SUV4.0阈值勾画的TMTV预后价值不显著。
  • SUV4.0阈值勾画的[18F]FDG高摄取病变VOI数量是PFS的独立预后因素。

研究设计与样本

  • 回顾性纳入比利时列日大学医院内部数据库中的初诊多发性骨髓瘤患者,共40例,均为适合移植者。
  • 所有PET/CT图像先用IMPeTUs标准进行视觉分析,再用半自动勾画流程以绝对SUV阈值4.0勾画[18F]FDG阳性局灶性病变并计算TMTV。
  • 先评估两名经验不同的核医学医师间一致性,再用单因素和多因素分析评估[18F]FDG PET/CT参数对PFS和OS的预后意义。

主要发现

  • 脊柱局灶性病变、脊柱外局灶性病变、至少一处骨折和椎旁病变的观察者间一致性为高度(Cohen's kappa分别为0.79、0.87、0.75和0.64)。
  • 颅骨局灶性病变和髓外病变的观察者间一致性为中等(Cohen's kappa分别为0.56和0.53)。
  • SUV4.0阈值勾画的VOI数量多是PFS的唯一独立预后因素[HR 1.03(95%CI 1.004–1.05),P=0.019]。
  • 局灶性病变数>10个(F组4)是OS的唯一独立预后因素[HR 19.10(95%CI 1.90–191.95),P=0.01]。
  • SUV4.0阈值勾画的TMTV预后价值不显著。

关键数值与推荐

  • IMPeTUs视觉标准评估项目包括脊柱局灶性病变、脊柱外局灶性病变、颅骨局灶性病变、至少一处骨折、椎旁病变和髓外病变。
  • TMTV勾画采用半自动病变勾画流程,纳入[18F]FDG阳性MM局灶性病变,绝对SUV阈值设为4.0。
  • PFS独立预后因素为SUV4.0阈值下勾画的VOI数量多[HR 1.03(95%CI 1.004–1.05),P=0.019]。
  • OS独立预后因素为局灶性病变数>10个(IMPeTUs F组4)[HR 19.10(95%CI 1.90–191.95),P=0.01]。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography combined with low-dose computed tomography (PET/CT) can be used at diagnosis to identify myeloma-defining events and also provides prognostic factors. The aim of this study was to assess the prognostic significance of baseline [18F]FDG PET/CT visual IMPeTUs (Italian myeloma criteria for PET Use)-based parameters and/or total metabolic tumor volume (TMTV) in a single-center population of patients with newly diagnosed multiple myeloma (NDMM) eligible for transplantation. METHODS: Patients with MM who underwent a baseline [18F]FDG PET/CT were retrospectively selected from a large internal database of the University Hospital of Liege (Liege, Belgium). Initially, all PET/CT images were visually analyzed using IMPeTUs criteria, followed by delineation of TMTV using a semi-automatic lesion delineation workflow, including [18F]FDG-positive MM focal lesions (FL) with an absolute SUV threshold set at 4.0. In a first step, to ensure PET/CT scans accurate reporting, the agreement between two nuclear medicine physicians with distinct experience was assessed. In the second step, univariable and multivariable analyses were conducted to determine the prognostic significance of [18F]FDG PET/CT parameters on progression free survival (PFS) and overall survival (OS), respectively. RESULTS: A total of 40 patients with NDMM were included in the study. The observers agreement in the analysis [18F]FDG PET/CT images was substantial for the presence of spine FL, extra spine FL, at least one fracture and paramedullary disease (Cohen's kappa 0.79, 0.87, 0.75 and 0.64, respectively). For the presence of skull FL and extramedullary disease the agreement was moderate (Cohen's kappa 0.56 and 0.53, respectively). Among [18F]FDG PET/CT parameters, a high number of delineated volumes of interest (VOI) using the SUV4.0 threshold was the only independent prognostic factor associated with PFS [HR (95% CI): 1.03 (1.004-1.05), P = 0.019] while a high number of FL (n > 10; F group 4) was the only independent prognostic factor associated with OS [HR (95% CI): 19.10 (1.90-191.95), P = 0.01]. CONCLUSION: Our work confirms the reproducibility IMPeTUs criteria. Furthermore, it demonstrates that a high number of FL (n > 10; IMPeTUs F group 4), reflecting a high [18F]FDG-avid tumor burden, is an independent prognostic factor for OS. The prognostic value of the TMTV delineated using a SUV4.0 threshold was not significant. Nevertheless, the count of delineated [18F]FDG-avid lesions VOI using a SUV4.0 threshold was an independent prognostic factor for PFS.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Marchiori S, Cousin F, Papadopoulos I, et al. Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [18F]FDG PET/CT in patients with newly diagnosed multiple myeloma. EJNMMI Res. 2024. PMID: 38806885. doi:10.1186/s13550-024-01113-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。